Evidence map›Paper›PMID 34448071›Full record

ArticleJournal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry2021

Synthesis and evaluation of iridium(III) complexes on antineoplastic activity against human gastric carcinoma SGC-7901 cells.

Li Tian, Yuanyuan Zhang, Huiwen Zhang, Yi Zhou, Wenlong Li, Yuhan Yuan, Jing Hao, Linlin Yang, Yunjun Liu

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Synthesis, characterization, anticancer efficacy evaluation of ruthenium(II) and iridium(III) polypyridyl complexes toward A549 cells.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2023
    Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Li TianSchool of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, 510006, People's Republic of China.
Yuanyuan ZhangSchool of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, 510006, People's Republic of China.
Huiwen ZhangSchool of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, 510006, People's Republic of China.
Yi ZhouSchool of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, 510006, People's Republic of China.
Wenlong LiSchool of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, 510006, People's Republic of China.
Yuhan YuanSchool of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, 510006, People's Republic of China.
Jing HaoSchool of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, 510006, People's Republic of China.
Linlin YangDepartment of Pediatrics, Guangdong Women and Children Hospital, Guangzhou, 510010, People's Republic of China. lyjche@gdpu.edu.cn.
Yunjun LiuSchool of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, 510006, People's Republic of China. yanglinlin@gzhmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The study was intended to determine the antineoplastic effects of two new iridium(III) complexes [Ir(ppy)

Indexed as

AnimalsAntineoplastic AgentsApoptosisCell Line, TumorCell SurvivalHumansIridiumMiceMice, NudeMolecular StructureStomach NeoplasmsXenograft Model Antitumor AssaysAntineoplastic AgentsIridiumAnticancer effects in vivoApoptosisIridium(III) complexesMitochondrial membrane potentialWestern blot analysis

Identifiers

PMID34448071

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.